Sources

9 Total Sources

Biogen’s diranersen cuts tau 50%-65%, slows early Alzheimer’s decline by 26%

Left60%

Center20%

Right20%

The Associated Press2h ago

Biogen's Diranersen Shows Promise in Early Alzheimer's by Lowering Tau Protein

Biogen Alzheimer's drug slowed cognitive decline in midstage study

Biogen's Alzheimer's drug lowers toxic protein, but results were mixed | The Mighty 790 KFGO | KFGO

abcnews.com2h ago

Biogen's Diranersen Shows Promise in Slowing Early Alzheimer's by Lowering Tau Protein

StockTitan3h ago

Biogen Diranersen Phase 2 Shows 50% MMSE Slowing | BIIB Stock News

Endpoints News3h ago

Biogen's tau drug reports mixed Alzheimer's results, as low dose performs better

Fierce Biotech3h ago

AAIC: Biogen bolsters hopes for pivotal anti-tau push

An experimental Alzheimer's drug shows some promise as researchers hunt new approaches - Newsday

Biogen | Investor Relations17h ago

Biogen's Diranersen Phase 2 CELIA Data Shows 26% Slower Alzheimer's Decline, 50-65% Tau Reduction